Due to its selective expression in CAFs, minimal presence in normal tissue, and critical role in tumor progression, FAP has emerged as a promising clinical target, driving the development of novel strategies for imaging, radioligand therapy, and targeted drug delivery. Here, FAP is linked to neoplasm.